5661 DAN (Sulindac 150 mg)
Pill with imprint 5661 DAN is Yellow, Round and has been identified as Sulindac 150 mg. It is supplied by Watson Laboratories, Inc.
Sulindac is used in the treatment of gout, acute; bursitis; ankylosing spondylitis; familial adenomatous polyposis; juvenile rheumatoid arthritis and belongs to the drug class Nonsteroidal anti-inflammatory drugs. Risk cannot be ruled out during pregnancy. Sulindac 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 5661 DAN
Sulindac
- Imprint
- 5661 DAN
- Strength
- 150 mg
- Color
- Yellow
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Nonsteroidal anti-inflammatory drugs
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Laboratories, Inc.
- Inactive Ingredients
-
magnesium stearate,
microcrystalline cellulose,
stearic acid,
corn starch
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00591-5661 | Watson Pharmaceuticals, Inc. |
| 66267-0264 (Discontinued) | Nucare Pharmaceuticals Inc. (repackager) |
| 54868-0879 (Discontinued) | Physicians Total Care Inc. (repackager) |
More about sulindac
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (26)
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: Nonsteroidal anti-inflammatory drugs
Patient resources
- Other brands
- Clinoril
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.